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Focal Nodular Hyperplasia with
Retraction of Liver Capsule:
A Case Report
Focal nodular hyperplasia (FNH) is characterized by the presence a central
scar with radiating fibrous septa. Our case had a capsular retraction, which was
the result of an extension of the central scar to the surface. In addition, a
hypointense scar on the T2-weighted image and a minimal enhancing central
scar on the enhanced T1-weighted image, which was due to dense, sclerotic col-
lagenous tissue, were observed. We report the first case of FNH with a capsular
retraction.
ocal nodular hyperplasia (FNH) is the second most common benign he-
patic tumor next to hemangioma (1). It is mainly found in young women.
Generally, FNH presents as a solitary nodule < 5-cm in diameter near the
liver surface (1, 2). The mass is usually lobulated and well circumscribed. The charac-
teristic macroscopic features is the presence of a central scar with radiating fibrous sep-
ta, dividing the lesion into numerous nodules of normal hepatocytes, which are abnor-
mally arranged (2).
A retraction of the liver capsule adjacent to the tumor is an unusual finding. The im-
age findings of the peripheral hepatic masses with a capsular retraction can be ob-
served in some malignant hepatic tumors, such as a hepatocellular carcinoma, a pe-
ripheral cholangiocarcinoma, a metastasis (3, 4), and a hepatic epithelioid hemangioen-
dothelioma (5). However, this finding has seldom been associated with a benign tu-
mor.
Several atypical imaging findings exist in FNH (1), but there is no report showing a
capsular retraction. We report the atypical imaging findings of FNH, which showed a
capsular retraction.
CASE REPORT
The patient was a 28-year-old woman who was admitted to hospital because of a he-
patic mass found incidentally on screening sonography. She had no previous surgical
and medical problems. A physical examination and the laboratory findings on admis-
sion revealed no abnormalities. The serum alpha-fetoprotein level was 1.2 ng/mL and
the carcinoembryonic antigen level was 1.3 ng/mL. Test for the hepatitis-B antigen
was negative and the test for hepatitis-B antibodies was positive.
CT of the abdomen showed a mass in the segment 6 measuring approximately 4.0
3.8-cm with a capsular retraction. The hepatic helical CT scan during the hepatic arter-
ial phase showed a heterogeneously enhancing mass with a lobulated margin. A cen-
tral scar was shown as a stellate hypoattenuation. The hepatic helical CT scan during
the portal phase showed an isodense mass with a hypodense central scar (Fig. 1A).
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FThese findings were compatible with the focal nodular hy-
perplasia except for a central scar extension to the hepatic
capsule causing a retraction. The T1-weighted axial MR im-
age of the liver demonstrated a slightly hypointense mass
demarcated by a thin hypointense rim with a central hy-
pointense scar. The T2-weighted axial MR image showed a
slightly hyperintense mass with a hypointense central scar.
The contrast-enhanced T1-weighted axial MR image re-
vealed a marked enhancement of the tumor with a nonen-
hancing central scar (Fig. 1B).
Segment 6 of the liver was resected. The gross specimen
showed a nodular configuration with a dense fibrotic cen-
tral scar. On the cut surface, a central dense fibrotic scar
with radiating fibrous septa dividing the lesion into smaller
nodules was noted (Fig. 1C). The central scar extended to
the surface, and the surface of the liver parenchyma adja-
cent to the mass was retracted. The capsular retraction of
the liver surface was attributed to the collagenous scar. The
resected specimen showed a depressed thickened stellate
scar, slightly eccentrically positioned, with tapering fibrous
septa, which radiated through the mass, dividing it into
multiple lobules. The patient took an uneventful postoper-
ative course and was discharged.
DISCUSSION
Focal nodular hyperplasia (FNH) is found predominantly
in women during the third to fifth decade of life. However,
it has been reported to occur in both sexes and in all age
groups. Most commonly, it is found incidentally in asymp-
tomatic patients. The cause of FNH is not well understood,
but a congenital vascular malformation or vascular injury
has been suggested to be an underlying mechanism for the
hepatocelluar hyperplasia (2).
FNH is classically seen as a solitary, homogeneous, and
slightly hypoattenuating or isoattenuating area compared
to the normal liver on unenhanced CT (1). In approximate-
ly 20% of patients, a central low-attenuating scar may be
observed (6). On enhanced CT, FNH shows an immediate
and intense enhancement, with the exception of a central
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Fig. 1. A. 28-year-old woman with focal nodular hyperplasia with a
retraction of the liver capsule. On hepatic helical CT scan during
the portal phase, the mass shows an iso-attenuation with the liver
parenchyma. The mass has a central fibrotic scar (small black ar-
rows), and the liver capsule adjacent to the mass is retracted (large
arrow).
B. Contrast enhanced T1-weighted MR image reveals that the tu-
mor is well enhanced with a minimally enhancing central scar
(small black arrows). The lateral surface of the liver parenchyma
adjacent to the mass is retracted (large arrow).
C. The hepatic mass of segment 6 is measures approximately 3.5
5.5 cm. The cut surface of the mass reveals a nodular configura-
tion with a central fibrous scar, extending to the liver surface (white
arrow). The resected specimen shows a depressed thickened stel-
late scar (black arrows), slightly eccentrically positioned, with taper-
ing fibrous septa that radiate through the mass, dividing it into mul-
tiple lobules.
Cscar with a delayed enhancement, possibly due to abun-
dant fibrous stroma (6). The atypical imaging findings of
FNH include hemorrhage, necrosis, fat accumulation on an
unenhanced CT, rapid contrast washout, delayed contrast
accumulation, or the absence of a central scar (1, 2).
The MR imaging of typical FNH is iso- or slightly hy-
pointense mass with hypointense scar on the T1-weighted
MR imaging and a slightly hyperintense mass with a hyper-
intense scar on the T2-weighted image. Intensely and im-
mediately enhancing mass with a delayed enhancing cen-
tral scar is a classic finding on the Gadolinum enhanced
MR (1, 2). According to Vilgrain et al (7), when the firosis,
edema, vessels, and inflammation of the central scars were
carefully studied, obliterative vascular changes were ob-
served in both hyperintense and hypointense scars on the
T2-weighted images. They reported that the distribution of
fibrosis, inflammation, and vessels were not different in the
hyper- and hypointense scars, but most of the hyperintense
scars had predominant edema, whereas the hypointense
scars showed an absence of or a lower degree of edema
(7). A similar correlation between the pathology findings
and MR imaging was done to evaluate the central scars of
the primary liver tumor (8). Rummeny et al (8) described
three pathologic types of the central scars: (a) vascular
scars composed mainly of vascular channels penetrating
the collagenous tissue; (b) inflammatory scars with edema,
necrosis, hepatocellularity and loose connective tissue; and
(c) collagenous scars composed predominantly of dense,
sclerotic collagen. Vascular and inflammatory scars ap-
peared hypointense relative to the liver parenchyma on
the T1-weighted images, and hyperintense on the T2-
weighted images, while collagenous scars were hy-
pointense on both the T1- and T2-weighted images. In our
case, the microscopic findings showed a collagenous scar
composed mainly of dense, sclerotic collagen, which ex-
plains the cause of the hypointensity on the T2-weighted
image and a minimal enhancing central scar on the en-
hanced T1-weighted image.
The cut surface of a typical FNH revealed a central stel-
late scar with radiating fibrous septa dividing the lesion in-
to smaller nodules. The central scar contained thick-walled
vessels that provided arterial blood supply to the lesion (2).
Grossly, the resected specimen showed a depressed thick-
ened stellate scar, slightly eccentrically positioned, with ta-
pering fibrous septa that radiated through the mass, divid-
ing it into multiple lobules. Microscopically, numerous fi-
brous bands of varying thickness divided the lesion, sur-
rounding the nodules of the hyperplastic hepatocytes and
converging at the central scar. Several large blood vessels,
which exhibited varying degrees of myointimal hyperpla-
sia, mural thickening and intimal narrowing, were ob-
served within the dense collagenous scar. These radiating
septa contained numerous thin-walled vessels, lymphocyte
infiltrates and numerous proliferated bile ducts, which
were closely apposed to the periseptal hepatocytes. The
hepatocytes nodules were composed of normal parenchy-
mal elements, which were irregularly arranged with plates
of one or two cells’ thickness but the normal lobular archi-
tecture was not seen.
A capsular retraction of the liver adjacent to the hepatic
mass is an uncommon finding. Soyer et al. (3) reported that
the prevalence of the capsular retraction adjacent to the
hepatic tumor was 2% and all tumors were malignant. Seo
et al (4) suggested that the prevalence was approximately
12% in malignant hepatic masses. These findings have
been observed in cases of hepatic epitheloid hemangioen-
dothelioma (HEH), hepatocellular carcinoma, intrahepatic
cholangiocarcinoma, and metastases from colon and breast
cancers (3 5, 10). The capsular retraction of HEH was
most likely due to the tumor fibrous reaction, which dis-
torted the tumor margin and the adjacent liver capsule (5).
The main factors causing the capsular retraction in malig-
nant hepatic tumors are a portal venous obstruction in the
hepatocelluar carcinoma, and hepatic atrophy followed by
a bile duct obstruction in a cholangiocarcinoma (4). Soyer
et al. (3) reported that this finding was never associated
with a benign tumor, supporting the hypothesis that a re-
traction of the liver capsule adjacent to a hepatic tumor is a
finding specific to malignant tumors. Recently, Yang et al.
(9) reported a capsular retraction in hepatic giant heman-
gioma. A capsular retraction with hemangiomas in cirrhotic
livers has also been described (10).
Although Blachar (10) reported that the hemangioma
was the only benign neoplasm associated with a capsular
retraction, this study found another benign hepatic mass
with a capsular retraction. This is the first report showing a
capsular retraction in focal nodular hyperplasia. In this
case, the central fibrotic scar within the tumor was extend-
ed to the surface, and a retraction of the liver capsule adja-
cent to the tumor was made.
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